Viewing Study NCT03328494

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:00 AM
Ignite Modification Date: 2026-02-22 @ 1:03 AM
Study NCT ID: NCT03328494
Status: COMPLETED
Last Update Posted: 2021-04-15
First Post: 2017-10-30
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Paclitaxel in Combination With BOS172722 in Patients With Advanced Nonhaematologic Malignancies
Sponsor: Boston Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Nonhaematologic Malignancies View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Paclitaxel View
None BOS172722 View
None triple-negative breast cancer View